Vizgen and Hamamatsu Enhance Biomarker Research Collaboration
Vizgen and Hamamatsu Join Forces for Innovative Solutions
In a significant move for the life sciences sector, Vizgen, Inc. has forged a partnership with Hamamatsu Photonics K.K. This collaboration aims to usher in an era of enhanced spatial multi-omics by combining Hamamatsu's advanced imaging systems with Vizgen's high-quality reagents and assays. The integration of their technologies is set to provide researchers with efficient solutions for biomarker detection, making strides in both translational and clinical research.
Streamlining Multiplex Assays
The partnership is focused on overcoming common hurdles in multiplex assay development. By simplifying workflow integration and speeding up the validation process, researchers can dedicate more time to obtaining critical biological insights. This collaboration promises to refine the acquisition process and enhance the quality of results obtained, taking advantage of both companies' strengths.
Advanced Imaging Capabilities
Hamamatsu's MoxiePlex™ platform stands out by enabling up to nine-color imaging while maintaining high throughput. With the capacity to handle up to 60 slides per run, this technology is particularly beneficial for high-volume laboratories. Coupled with Vizgen’s InSituPlex® assays, which facilitate the rapid deployment of customized research panels featuring pre-validated biomarkers, labs can minimize waiting times for data collection while ensuring high specificity and reproducibility.
Empowering Research Labs
Together, Vizgen and Hamamatsu are combining their expertise to create a robust solution for validated InSituPlex panels integrated with MoxiePlex technology. This collaboration targets multi-site deployments specifically designed for translational and clinical research applications. One of the initial projects focuses on using mIF panels for research on non-small cell lung cancer (NSCLC) specimens, demonstrating the potential impact of their partnership.
Vision for Translational Research
In the words of Rob Carson, CEO of Vizgen, this partnership is a convergence of two technology leaders pursuing a common vision for impactful translational research. By merging automated imaging capabilities with expertise in protein assays, they aim to deliver comprehensive sample-to-answer insights, ultimately benefiting a broader spectrum of researchers in the scientific community.
About Vizgen
Vizgen is recognized for its cutting-edge contributions to spatial biology and multi-omics innovation. With their pioneering MERFISH technology and MERSCOPE® platform, they specialize in in situ single-cell spatial genomics. Additionally, their high-fidelity InSituPlex® protein assays and AI-driven STARVUE™ spatial image analysis technology equip researchers with the tools necessary to uncover profound insights into human biology. These innovations play crucial roles in comprehending complex disease mechanisms such as neurodegenerative disorders and cancer.
About Hamamatsu Photonics
Hamamatsu Photonics stands at the forefront of photonics technology, providing advanced imaging and optical systems. Their MoxiePlex™ system, a state-of-the-art 9-color multiplex immunofluorescence imaging platform, significantly propels the field of spatial proteomics from research to clinical applications, initially targeting immuno-oncology and aiming for broader translational pathology tasks.
Frequently Asked Questions
What is the main goal of the Vizgen and Hamamatsu partnership?
The partnership aims to streamline spatial biology workflows by integrating advanced imaging systems and high-quality reagent technologies.
How does the MoxiePlex™ platform enhance research capabilities?
MoxiePlex™ allows for up to nine-color imaging and high throughput, facilitating efficient multiplex assay development.
What applications will the integrated solution target?
The solution targets translational and clinical research applications, with initial projects focused on non-small cell lung cancer (NSCLC).
How does Vizgen contribute to the field of spatial biology?
Vizgen leverages technologies such as MERFISH and InSituPlex® to provide researchers with tools for uncovering insights into human biology.
What expertise does Hamamatsu bring to the collaboration?
Hamamatsu brings advanced photonics technology and experience in optical systems to enhance imaging capabilities for spatial proteomics.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
